Ascentage Pharma Group International (AAPG) Inventory Average (2024 - 2025)
Ascentage Pharma Group International posted quarterly Inventory Average of $2.6 million for Q4 2025, up 65.43% year-on-year from $1.6 million in Q4 2024, and up 147.19% on a QoQ basis from $1.1 million in Q2 2025.
Ascentage Pharma Group International (AAPG) has 2 years of Inventory Average data on file, last reported at $2.6 million in Q4 2025.
- For the quarter ending Q4 2025, Inventory Average rose 65.43% year-over-year to $2.6 million; the trailing twelve-month figure through Dec 2025 stood at $2.6 million (up 65.43% YoY), and the FY2025 full-year result was $2.5 million, up 58.63% from the prior year.
- Inventory Average for Q4 2025 stood at $2.6 million, up from $1.1 million in the prior quarter.
- Across five years, Inventory Average topped out at $2.6 million in Q4 2025 and bottomed at $1.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 3.15 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Ascentage Pharma Group International | 1.11 Bn | 937.28 Mn | - | 2.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.62 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Dec 31, 2024 | 1.58 Mn |